Vanadium: a possible aetiological factor in manic depressive illness

Psychol Med. 1981 May;11(2):249-56. doi: 10.1017/s0033291700052065.

Abstract

The effect of Vitamin C in manic-depressive psychosis was assessed by a double-blind, placebo controlled, crossover trial. Both manic and depressed patients were significantly better following a single 3 g dose of Vitamin C than following a placebo. Preliminary results of a double-blind, crossover comparison of normal vanadium intake with reduced intake in manic and depressed subjects are reported. Both manic and depressed patients were significantly better on reduced intake. These results are in keeping with the suggestion that vanadium may be an aetiological factor in manic depressive illness.

Publication types

  • Clinical Trial

MeSH terms

  • Ascorbic Acid / therapeutic use*
  • Bipolar Disorder / chemically induced*
  • Bipolar Disorder / diet therapy
  • Bipolar Disorder / drug therapy
  • Clinical Trials as Topic
  • Double-Blind Method
  • Edetic Acid / therapeutic use
  • Humans
  • Placebos
  • Vanadium / administration & dosage
  • Vanadium / toxicity*

Substances

  • Placebos
  • Vanadium
  • Edetic Acid
  • Ascorbic Acid